Proteomics and the haematologist.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical and Laboratory Haematology

• Publication date

  2004-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/J.1365-2257.2004.00598.XPMID 15053800
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma (KS): implications for the design of therapeutic trials in patients with advanced symptomatic KS.

  2004cited by this paper
• Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma.

  2004cited by this paper
• High‐throughput tissue microarray analysis of G1‐cyclin alterations in classical Hodgkin's lymphoma indicates overexpression of cyclin E1

  2003cited by this paper
• Proteomic Analysis of Chronic Lymphocytic Leukemia Subtypes with Mutated or Unmutated Ig VH Genes*

  2003cited by this paper
• Clinical proteomics: Written in blood

  2003cited by this paper
• Proteomic map and database of lymphoblastoid proteins.

  2002cited by this paper
• Identification of novel targets for cancer therapy using expression proteomics

  2002cited by this paper
• Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

  2002cited by this paper
• Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine.

  2001cited by this paper
• Correlation of clinical data with proteomics profiles in 24 patients with B‐cell chronic lymphocytic leukemia

  2001cited by this paper
• Two‐dimensional database of a Burkitt lymphoma cell line (DG 75) proteins: Protein pattern changes following treatment with 5′‐azycytidine

  2001cited by this paper
• Protein analysis by mass spectrometry and sequence database searching: A proteomic approach to identify human lymphoblastoid cell line proteins

  2000cited by this paper
• Molecular Cloning and Characterization of Two Novel Pro-apoptotic Isoforms of Caspase-10*

  1999cited by this paper
• Proteinchip® surface enhanced laser desorption/ionization (SELDI) mass spectrometry: a novel protein biochip technology for detection of prostate cancer biomarkers in complex protein mixtures

  1999cited by this paper
• Stress-induced secretion of growth inhibitors: a novel tumor suppressor function of p53

  1998cited by this paper
• Mass-sensing, multianalyte microarray immunoassay with imaging detection.

  1998cited by this paper
• A comparison of selected mRNA and protein abundances in human liver

  1997cited by this paper
• Membrane-bound proteindisulfide isomerase (PDI) is involved in regulation of surface expression of thiols and drug sensitivity of B-CLL cells.

  1997cited by this paper
• A model for p53-induced apoptosis

  1997cited by this paper
• Thioredoxin Peroxidase Is a Novel Inhibitor of Apoptosis with a Mechanism Distinct from That of Bcl-2*

  1997cited by this paper
• Two‐dimensional electrophoresis of proteins: An updated protocol and implications for a functional analysis of the genome

  1995cited by this paper
• Progress with gene‐product mapping of the Mollicutes: Mycoplasma genitalium

  1995cited by this paper
• Identification of two related markers for common acute lymphoblastic leukemia as heat shock proteins.

  1990cited by this paper
• Electrospray ionization for mass spectrometry of large biomolecules.

  1989cited by this paper
• Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons.

  1988cited by this paper
• Genetic analysis of thirty-three platelet polypeptides detected in two-dimensional polyacrylamide gels.

  1986cited by this paper
• High resolution two-dimensional electrophoresis of proteins.

  1975cited by this paper

• MALDI-TOF mass spectrometry as a diagnostic tool in human and veterinary helminthology: a systematic review

  2019cites this paper
• Prospects for Personalized Cardiovascular Medicine

  2016cites this paper
• Proteomic analysis of multiple myeloma: Current status and future perspectives

  2011cites this paper
• Gene expression profiling in MDS and AML: potential and future avenues

  2011cites this paper
• Stored red blood cells: a changing universe waiting for its map(s).

  2010cites this paper
• Proteomics, the red blood cell and transfusion medicine

  2010cites this paper
• How has proteomics informed transfusion biology so far?

  2010cites this paper
• Blood-related proteomics.

  2010cites this paper
• Mass spectrometry-based proteomics and its potential use in haematological research

  2009cites this paper
• Approaching clinical proteomics: current state and future fields of application in fluid proteomics

  2009cites this paper
• Chapter 17 – Applications of mass spectrometry in oncology

  2008cites this paper
• Transfusion medicine in the era of proteomics.

  2008cites this paper
• Proteomics: applications in transfusion medicine.

  2008cites this paper
• How will haematologists use proteomics?

  2007cites this paper
• Proteomics: applications relevant to transfusion medicine.

  2006cites this paper
• Value of proteomics applied to the follow-up in stem cell transplantation

  2006cites this paper
• Genomic analyses: a neonatology perspective.

  2006cites this paper
• Genomic medicine: genetic variation and its impact on the future of health care

  2005cites this paper
• A review of proteomics in cancer research.

  2005cites this paper
• Proteomics challenging medicine

  2005cites this paper
• Recent advances in blood‐related proteomics

  2005cites this paper
• Personalized diagnostic and therapeutic strategies in oncology.

  2005cites this paper
• Prospects for personalized cardiovascular medicine: the impact of genomics.

  2005cites this paper